Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Review Article 


Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview

Nutan Sham Nabar, Rama Ashok Vaidya, Chethala N Vishnuprasad, Shobha R Iyer, Chhaya S Godse, Ashok J Amonkar, Ashok DB Vaidya.

Abstract
Introduction
Diabetic patients often consume traditional medicines, available as over-the-counter products, concurrently with prescribed conventional medicines. A study of 180 marketed Ayurvedic antidiabetic formulations showed that Enicostema axillare subsp. littorale (Blume) A.Raynal (Mamajjakah) is being used frequently in several formulations by Ayurvedic industry, particularly from the Western India. The present overview covers the classical and current literature on the plant for its antidiabetic activity.
Materials and methods:
The classical Ayurvedic literature, the current texts of Dravyaguna Vidnyan, Ayurvedic journals as well as pharmacological literature on E. axillare have been reviewed for its Ayurvedic Dravyaguna rationale and antidiabetic activity.
Results:
The earliest description of the plant E. littorale has been found in Shodhal Nighantu (12th Century) with its various synonyms and its use as an antipyretic and anthelminthic drug. Medicinal properties of the plant in classical and other texts reveal that it can best be described as laghu (light), ruksha (dry), of tikta rasa (pungent taste), ushna veerya (hot potency) and katu vipak (after-effects like pungent taste). It ameliorates pitta and kapha doshas. Its main site of action is medodhatu (adipose tissue) having pramehaghna (antidiabetic) properties. The phytochemical studies show major molecules that have shown antidiabetic properties are swertiamarin, apigenin and isovitexin. Several in vitro studies have demonstrated its antioxidant and anti-inflammatory activities; while in vivo studies have shown antidiabetic, antihyperlipidemic, antihypertensive, antiobesity, nephroprotective, hepatoprotective as well as antioxidant and anti-inflammatory activities. Several clinical studies have reported safety and antidiabetic activity in diabetic as well as prediabetics patients. Besides these, the plant has also shown nephroprotective, genoprotective activities as well as insulin sensitization.
Conclusions:
Wide use of E. axillare in diabetes mellitus suggests a need for thorough survey of its Ayurvedic pharmaco-epidemiology and drug utilization. The emergent data would facilitate Reverse Pharmacological study of the plant in diabetic patients. There is a potential for developing a safe and validated phytopharmaceutical antidiabetic drug.

Key words: Diabetes, Ayurvedic Pharmacoepidemiology, Enicostemma axillare, Mamajjakah, Reverse Pharmacology


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Nutan Sham Nabar
Articles by Rama Ashok Vaidya
Articles by Chethala N Vishnuprasad
Articles by Shobha R Iyer
Articles by Chhaya S Godse
Articles by Ashok J Amonkar
Articles by Ashok DB Vaidya
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Nabar NS, Vaidya RA, CNV, SRI, Godse CS, Amonkar AJ, Vaidya AD. Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview. AAM. 2020; 9(4): 279-290. doi:10.5455/AAM.108879


Web Style

Nabar NS, Vaidya RA, CNV, SRI, Godse CS, Amonkar AJ, Vaidya AD. Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview. http://www.aamjournal.in/?mno=108879 [Access: January 06, 2021]. doi:10.5455/AAM.108879


AMA (American Medical Association) Style

Nabar NS, Vaidya RA, CNV, SRI, Godse CS, Amonkar AJ, Vaidya AD. Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview. AAM. 2020; 9(4): 279-290. doi:10.5455/AAM.108879



Vancouver/ICMJE Style

Nabar NS, Vaidya RA, CNV, SRI, Godse CS, Amonkar AJ, Vaidya AD. Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview. AAM. (2020), [cited January 06, 2021]; 9(4): 279-290. doi:10.5455/AAM.108879



Harvard Style

Nabar, N. S., Vaidya, . R. A., , . C. N. V., , . S. R. I., Godse, . C. S., Amonkar, . A. J. & Vaidya, . A. D. (2020) Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview. AAM, 9 (4), 279-290. doi:10.5455/AAM.108879



Turabian Style

Nabar, Nutan Sham, Rama Ashok Vaidya, Chethala N Vishnuprasad, Shobha R Iyer, Chhaya S Godse, Ashok J Amonkar, and Ashok DB Vaidya. 2020. Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview. Annals of Ayurvedic Medicine, 9 (4), 279-290. doi:10.5455/AAM.108879



Chicago Style

Nabar, Nutan Sham, Rama Ashok Vaidya, Chethala N Vishnuprasad, Shobha R Iyer, Chhaya S Godse, Ashok J Amonkar, and Ashok DB Vaidya. "Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview." Annals of Ayurvedic Medicine 9 (2020), 279-290. doi:10.5455/AAM.108879



MLA (The Modern Language Association) Style

Nabar, Nutan Sham, Rama Ashok Vaidya, Chethala N Vishnuprasad, Shobha R Iyer, Chhaya S Godse, Ashok J Amonkar, and Ashok DB Vaidya. "Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview." Annals of Ayurvedic Medicine 9.4 (2020), 279-290. Print. doi:10.5455/AAM.108879



APA (American Psychological Association) Style

Nabar, N. S., Vaidya, . R. A., , . C. N. V., , . S. R. I., Godse, . C. S., Amonkar, . A. J. & Vaidya, . A. D. (2020) Enicostema axillare subsp. littorale (Blume) A. Raynal for Type 2 Diabetes mellitus: An overview. Annals of Ayurvedic Medicine, 9 (4), 279-290. doi:10.5455/AAM.108879








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


DOAJ

Google Scholar,

DHARA (http://www.dharaonline.org)

Ayush Research Portal (http://ayushportal.nic.in/)

Member of 

COPE ( Committee on Publication Ethics)

ICoAJE - International Committee of Ayurveda Journal Editors

Listed In

UGC-CARE list of Journals (2019)

List of Journals stating that they follow the ICMJE Recommendations ( 2017) 

.................................................................

AAM confirms its adherence with guidelines and best practices published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf) from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; (http://doaj.org/bestpractice).

.................................................................................................

The articles in Annals of Ayurvedic Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial  Share Alike License (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited and distributed with the same licence as the original .

An Official Journal of 

 

 

IASTAM member logo

Benefit Programs | SSP Society for Scholarly Publishing
 
Articles published in AAM are now being given Plum X Metrics depending upon the social media attention the articles have received. The Plum Print next to each article shows the relative activity in the categories of metrics: Captures, Mentions, Social Media and Citations. Click on the abstract of the article to see social media related attention the article has recieved .
 
Indexed by PlumX Metrics as a blog source for published research ...


ABOUT JOURNAL
POLICIES
STATEMENTS